{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:39:02Z","timestamp":1773103142761,"version":"3.50.1"},"reference-count":55,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1507\/endocrj.ej17-0401","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T22:26:28Z","timestamp":1520375188000},"page":"509-519","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence of diverse complications and its association with karyotypes in Japanese adult women with Turner syndrome\u2014a questionnaire survey by the Foundation for Growth Science\u2014"],"prefix":"10.1507","volume":"65","author":[{"given":"Kunihiko","family":"Hanew","sequence":"first","affiliation":[{"name":"Growth Hormone Therapy Research Committee, Foundation for Growth Science, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Growth Hormone Therapy Research Committee, Foundation for Growth Science, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Horikawa","sequence":"additional","affiliation":[{"name":"Growth Hormone Therapy Research Committee, Foundation for Growth Science, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Growth Hormone Therapy Research Committee, Foundation for Growth Science, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Yokoya","sequence":"additional","affiliation":[{"name":"Growth Hormone Therapy Research Committee, Foundation for Growth Science, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 Elsheikh M, Dunger DB, Conway GS, Wass JA (2002) Turner\u2019s syndrome in adulthood. Endocr Rev 23: 120\u2013140."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Conway GS (2002) The impact and management of Turner\u2019s syndrome in adult life. Best Pract Res Clin Endocrinol Metab 16: 243\u2013261.","DOI":"10.1053\/beem.2002.0197"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Gravholt CH (2005) Clinical practice in Turner syndrome. Nat Clin Pract Endocrinol Metab 1: 41\u201352.","DOI":"10.1038\/ncpendmet0024"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Bondy CA (2007) Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 92: 10\u201325.","DOI":"10.1210\/jc.2006-1374"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Freriks K, Timmermans J, Beerendonk CC, Verhaak CM, Netea-Maier RT, et al. (2011) Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome. J Clin Endocrinol Metab 96: E1517\u2013E1526.","DOI":"10.1210\/jc.2011-0346"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Gawlik A, Gawlik T, Januszek-Tizciakowska A, Patel H, Malecka-Tendera E (2011) Incidence and dynamics of thyroid dysfunction and thyroid autoimmunity in girls with Turner\u2019s syndrome: a long term follow-up study. Horm Res Paediatr 76: 314\u2013320.","DOI":"10.1159\/000331050"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Hanew K, Tanaka T, Horikawa R, Hasegawa T, Fujita K, et al. (2016) Women with Turner syndrome are at high risk of lifestyle-related disease\u2014From questionnaire surveys by the Foundation for Growth Science in Japan. Endocr J 63: 449\u2013456.","DOI":"10.1507\/endocrj.EJ15-0288"},{"key":"8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1447-0756.2010.01448.x","volume":"37","author":"H Sakakibara","year":"2011","unstructured":"8 Sakakibara H, Yoshida H, Takei M, Katsuhata Y, Koyama M, et al. (2011) Health management of adults with Turner syndrome: an attempt at multidisciplinary medical care by gynecologists in cooperation with specialists from other fields. J Obstet Gynaecol Res 37: 836\u2013842.","journal-title":"Journal of Obstetrics and Gynaecology Research","ISSN":"https:\/\/id.crossref.org\/issn\/1341-8076","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Watanabe M (2012) Recent advances in the treatment of inflammatory bowel diseases. J Jpn Soc Intern Med 101: 643\u2013646 (In Japanese).","DOI":"10.2169\/naika.101.643"},{"key":"10","unstructured":"10 Niwa K, Akagi T, Ichikawa H, Ichida T, Ohshima Y, <i>et al.<\/i> (2006) Guidelines for management of congenital heart disease in adult. 2011 nendo godo kenkyuhan hokoku (2011 Report of the Joint Research Group) 1\u2013135 (In Japanese)."},{"key":"11","unstructured":"11 Tateno H, Niwa K (2008) Frequency of congenital heart disease. In: Niwa K, Nakazawa M, Akagi T, Tateno H (eds) Guidebook for adult congenital heart disease. Medical Review, Tokyo, Japan: 23\u201325. (In Japanese)"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Mihara M, Ito Y, Fukushima K, Yamashita F, Tsunosue M (1992) Ultrasonographic screening for renal abnormalities in three-year-old children. Acta Paediatr 81: 326\u2013328.","DOI":"10.1111\/j.1651-2227.1992.tb12236.x"},{"key":"13","unstructured":"13 Mishina T (1991) Congenital abnormalities of the urogenital system. In: Yoshida O (ed) Bedside Urology, Diagnosis and Treatment (2nd). Nankodo, Tokyo: 184\u2013186 (In Japanese)."},{"key":"14","unstructured":"14 Yamamoto I (1999) Estimation of osteoporosis population. Osteoporopsis Jpn 7: 10\u201311. (In Japanese)"},{"key":"15","unstructured":"15 Sukegawa A, Ito M, Abumi K, Kotani Y, Takahata M, <i>et al.<\/i> (2007) Survey of school screening of scoliosis in Sapporo City in 1989 to 2005. Hokkaido seikei saigai geka gakkai zasshi (The Hokkaido Journal of Orthopaedics and Traumatology) 48: 15 (In Japanese)."},{"key":"16","unstructured":"16 Statistics Bureau (2008) Genzai suikei jinkou (Estimated population of Japan as of October 1, 2008, Total population) Ministry of Internal Affairs and Communications http: \/\/www.stat.go.jp\/data\/jinsui\/2008np\/index.htmbc (In Japanese)."},{"key":"17","unstructured":"17 Yamauchi T (2009) Project for promotion of health and welfare for the disabled in 2009 (Survey and research project for assisting independent living by the disabled): survey of social resources to support independent living by patients with epilepsy (In Japanese)."},{"key":"18","unstructured":"18 Ministry of Health, Labour and Welfare (2008) Kanja chosa Heisei 20 nendo (Patient survey 2008) http:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/kanja\/08\/index.html (In Japanese)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Shoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA (2008) Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93: 4735\u20134742.","DOI":"10.1210\/jc.2008-1049"},{"key":"20","unstructured":"20 Kleczkowska A, Kubien E, Fryns JP, Van den Berghe H (1990) Turner Syndrome: the Leuven experience (1965\u20131989) in 478 patients. I. Patient\u2019s age at the time of diagnosis in relation to chromosomal findings. Genetic Couns 1: 235\u2013240."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Hook EB, Warburton D (1983) The distribution of chromosomal genotypes associated with Turner\u2019s syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet 64: 24\u201327.","DOI":"10.1007\/BF00289473"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Fiot E, Zenaty D, Boizeau P, Haigner\u00eb J, Dos Santos S, et al. (2016) X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome. Eur J Endocrinol 174: 281\u2013288.","DOI":"10.1530\/EJE-15-1000"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Tanaka T, Hibi I, Shizume K (1991) Study of growth hormone (GH) secretion capacity and efficacy of GH therapy in Turner syndrome: comparison with pituitary dwarfism. Nihon Naibumpitsu Gakkai Zasshi 67: 597\u2013610 (In Japanese).","DOI":"10.1507\/endocrine1927.67.5_597"},{"key":"24","unstructured":"24 Shimura H (2008) Subclinical hypothyroidism. Survey of subclinical hypothyroidism and guide to its treatment: frequency of subclinical hypothyroidism and subclinical hyperthyroidism detected by thorough health check-up. Horumon to rinsho (Clinical Endocrinology) 56: 673\u2013678 (In Japanese)."},{"key":"25","unstructured":"25 Kasagi K, Takahashi N, Inoue G, Honda T, Kawachi Y (2009) Thyroid function in subjects receiving through health check-up. Ningen dokku (Complete medical checkup) 24: 74\u201383 (In Japanese)."},{"key":"26","unstructured":"26 Niimi H (2001) Thyroid disease, autoimmune disease. In: Okada Y (ed) Turner syndrome. Medical View, Tokyo: 185\u2013192 (In Japanese)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Gawlik A, Malecka-Tendera E (2013) Transitions in endocrinology: treatment of Turner\u2019s syndrome during transition. Eur J Endocrinol 170: R57\u2013R74.","DOI":"10.1530\/EJE-13-0900"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Fukuda I, Hizuka N, Kurimoto M, Morita J, Tanaka S, et al. (2009) Autoimmune thyroid disease in 65 Japanese women with Turner syndrome. Endocr J 56: 983\u2013986.","DOI":"10.1507\/endocrj.K09E-141"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Bettendorf M, Doerr HG, Hauffa BP, Lindberg A, Mehls O, et al. (2006) Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment. J Pediatr Endocrinol Metab 19: 149\u2013154.","DOI":"10.1515\/JPEM.2006.19.2.149"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Ostberg JE, Conway GS (2003) Adulthood in women with Turner syndrome. Horm Res 59: 211\u2013221.","DOI":"10.1159\/000070220"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Betteridge JD, Armbruster SP, Maydonovitch C, Veerappan GR (2013) Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflamm Bowel Dis 19: 1421\u20131427.","DOI":"10.1097\/MIB.0b013e318281334d"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Donadille B, Rousseau A, Zenaty D, Cabrol S, Courtillot C, et al. (2012) Cardiovascular findings and management in Turner syndrome: insights from a French cohort. Eur J Endocrinol 167: 517\u2013522.","DOI":"10.1530\/EJE-12-0434"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Jevalikar GS, Zacharin M, White M, Yau SW, Li W, et al. (2015) Turner syndrome patients with bicuspid aortic valves and renal malformations exhibit abnormal expression of X-linked inhibitor of apoptosis protein (XIAP). J Pediatr Endocrinol Metab 28: 1203\u20131208.","DOI":"10.1515\/jpem-2014-0208"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Carrascosa A, Gussinye M, Terradas P, Yeste D, Audi L, et al. (2000) Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res 15: 2005\u20132010.","DOI":"10.1359\/jbmr.2000.15.10.2005"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Aso K, Koto S, Higuchi A, Ariyasu D, Izawa M, et al. (2010) Serum FSH level below 10 mIU\/mL at twelve years old is an index of spontaneous and cyclic menstruation in Turner syndrome. Endocr J 57: 909\u2013913.","DOI":"10.1507\/endocrj.K10E-092"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G (1997) Spontaneous pubertal development in Turner\u2019s syndrome. J Clin Endocrinol Metab 82: 1810\u20131813.","DOI":"10.1210\/jc.82.6.1810"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Nakamura T, Tsuburai T, Tokinaga A, Nakajima I, Kitayama R, et al. (2015) Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome. Endocr J 62: 965\u2013970.","DOI":"10.1507\/endocrj.EJ15-0172"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Lanes R, Gunczler P, Essa S, Martinis R, Villaroel O, et al. (1999) Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner\u2019s syndrome and previously normal bone density. Fertil Steril 72: 896\u2013899.","DOI":"10.1016\/S0015-0282(99)00389-1"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Stepan JJ, Musilova J, Pacovsky V (1989) Bone demineralization, biochemical indices of bone remolding, and estrogen replacement therapy in adults with Turner\u2019s syndrome. J Bone Miner Res 4: 193\u2013198.","DOI":"10.1002\/jbmr.5650040210"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Ari M, Bakalov VK, Hill S, Bondy CA (2006) The effects of growth hormone treatment on bone mineral density and body composition in girls with Turner syndrome. J Clin Endocrinol Metab 91: 4302\u20134305.","DOI":"10.1210\/jc.2006-1351"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Hasegawa Y, Ariyasu D, Izawa M, Igaki-Miyamoto J, Fukama M, et al. (2017) Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD. Endocr J 64: 221\u2013227.","DOI":"10.1507\/endocrj.EJ16-0170"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Bakalov VK, Axelrod L, Baron J, Hanton L, Nelson LM, et al. (2003) Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab 88: 5717\u20135722.","DOI":"10.1210\/jc.2003-030913"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Faienza MF, Ventura A, Colucci S, Cavallo L, Grano M, et al. (2016) Bone fragility in Turner syndrome: mechanisms and prevention strategies. Front Endocrinol (Lausanne) 7: 34.","DOI":"10.3389\/fendo.2016.00034"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Kim JY, Rosenfeld SR, Keyak JH (2001) Increased prevalence of scoliosis in Turner syndrome. J Pediatr Orthop 21: 765\u2013766.","DOI":"10.1097\/01241398-200111000-00012"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Elder DA, Roper MG, Henderson RC, Davenport ML (2002) Kyphosis in a Turner syndrome population. Pediatrics 109: e93.","DOI":"10.1542\/peds.109.6.e93"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Day GA, McPhee IB, Batch J, Tomlinson FH (2007) Growth rate and the prevalence and progression of scoliosis in short-statured children on Australian growth hormone treatment programmes. Scoliosis 2: 3.","DOI":"10.1186\/1748-7161-2-3"},{"key":"47","unstructured":"47 Ricotti S, Petrucci L, Carenzio G, Klersy C, Calcaterra V, et al. (2011) Prevalence and incidence of scoliosis in Turner syndrome: a study in 49 girls followed-up for 4 years. Eur J Phys Rehabil Med 47: 447\u2013453."},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Day G, Szvetko A, Griffiths L, McPhee IB, Tuffley J, et al. (2009) SHOX gene is expressed in vertebral body growth plates in idiopathic and congenital scoliosis: implications for the etiology of scoliosis in Turner syndrome. J Orthop Res 27: 807\u2013813.","DOI":"10.1002\/jor.20801"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Boman UW, Bryman I, M\u00f6ller A (2004) Psychological well-being in women with Turner syndrome: somatic and social correlates. J Psychosom Obstet Gynecol 25: 211\u2013219.","DOI":"10.1080\/01674820400017855"},{"key":"50","unstructured":"50 Nishi Y (2001) Hearing loss and ear\/nose diseases. In: Okada Y (ed) Turner syndrome. Medical Review, Tokyo: 215\u2013217 (In Japanese)."},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Sylven L, Hagenfeldt K, Brondum-Nielsen, Von Schoultz B (1991) Middle-aged women with Turner\u2019s syndrome. Medical status, hormonal treatment and social life. Acta Endocrinologica (Copenh) 125: 359\u2013365.","DOI":"10.1530\/acta.0.1250359"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Hultcrantz M, Sylven L (1997) Turner\u2019s syndrome and hearing disorders in women aged 16\u201334. Hear Res 103: 69\u201374.","DOI":"10.1016\/S0378-5955(96)00165-7"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Vulliemoz S, Dahoun S, Seeck M (2007) Bilateral temporal lobe epilepsy in a patient with Turner syndrome mosaicism. Seizure 16: 261\u2013265.","DOI":"10.1016\/j.seizure.2006.11.008"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Tsuboi T, Nielsen J (1985) Electroencephalographic examination of 64 Danish Turner girls. Acta Neurol Scand 72: 590\u2013601.","DOI":"10.1111\/j.1600-0404.1985.tb00919.x"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Prior TI, Chue PS, Tibbo P (2000) Investigation of Turner syndrome in schizophrenia. Am J Med Genet 96: 373\u2013378.","DOI":"10.1002\/1096-8628(20000612)96:3<373::AID-AJMG26>3.0.CO;2-Z"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/5\/65_EJ17-0401\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T09:17:33Z","timestamp":1570871853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/5\/65_EJ17-0401\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0401","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}